Table 2.
Non-adherence across prevalence of ten leading co-morbidities
| N non-adherent/N adherent | P value* | |||
|---|---|---|---|---|
| Never | At baseline | During follow-up | ||
| Chronic pulmonary disease | 881/3377 | 55/191 | 44/97 | 0.01 |
| Cerebrovascular disease | 907/3459 | 40/108 | 33/98 | 0.09 |
| Diabetes without complications | 908/3405 | 49/161 | 23/99 | 0.62 |
| Congestive heart failure | 937/3535 | 18/56 | 25/74 | 0.43 |
| Connective tissue and rheumatic disease | 945/3555 | 19/72 | 16/38 | 0.30 |
| Myocardial infarction | 949/3607 | 14/29 | 17/29 | 0.007 |
| Diabetes with complications | 960/3606 | 12/36 | 8/23 | 0.59 |
| Other cancer(s) | 960/3583 | 20/82 | 0/0 | 0.81 |
| Dementia | 960/3611 | 4/10 | 16/44 | 0.40 |
| Peripheral vascular disease | 964/3606 | 10/24 | 6/35 | 0.32 |
| Peptic ulcer disease | 965/3614 | 2/23 | 13/28 | 0.07 |
| Renal disease | 967/3627 | 5/12 | 8/26 | 0.55 |
| Paraplegia and hemiplegia | 970/3642 | 4/10 | 6/13 | 0.33 |
| Moderate or severe liver disease | 978/3656 | 1/3 | 1/6 | 0.99 |
*Fisher’s exact P value